Rheologics buys blood vessel imaging company
This article was originally published in Clinica
Executive Summary
Rheologics, which has developed a point-of-care whole blood viscosity measurement technology, has bought Cytometrics. The Delaware company develops non invasive point-of-care instrumentation for blood vessel imaging, which allows for better monitoring of perfusion changes in internal organs and in post-surgical disease states and requires no dye or surgery.